Stockreport

Lexicon Pharmaceuticals Knocked Back By The FDA's Rejection Of Zynquista [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Lexicon Pharmaceuticals Knocked Back By The FDA's Rejection Of Zynquista Summary The FDA has rejected Zynquista for Type 1 diabetes, and neither Sanofi nor Lexicon offer [Read more]